Sencilia

Sencilia is an early-stage DeepTech/MedTech startup (spin off from the University of Groningen) with a mission to improve the safety and reliability of IV infusion therapy. We develop innovative sensor technology that is designed to enhance patient safety in neonatal, pediatric and adult intensive care by reducing the risk of IV infusion-related adverse drug events. Contact us to know more!(Disclaimer: This device is under development. It is an investigational device and is not available for commercial sale or clinical use in any jurisdiction. It has not been CE marked or cleared by any regulatory authority. The information and any performance data presented are preliminary and for informational purposes only.)